Literature DB >> 22642906

A historical perspective on sepsis.

Peter A Ward1, Markus Bosmann.   

Abstract

In North America, approximately 700,000 cases of sepsis occur each year, with mortality ranging between 30% and 50%. The American Journal of Pathology has featured numerous articles on the topic, revealing mechanistic insights gleaned from both experimental rodent models and human sepsis. Nonetheless, there remains urgent need to determine the basis for sepsis-related complications and how they can be avoided, as well as how they can be most effectively treated once recognized. This historical perspective reviews what we currently understand about the mechanisms of sepsis, as well as the barriers that remain in our treatment strategies.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22642906      PMCID: PMC3388164          DOI: 10.1016/j.ajpath.2012.05.003

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  Editorial: PD-1, a new target for sepsis treatment: better late than never.

Authors:  Sanna M Goyert; Jack Silver
Journal:  J Leukoc Biol       Date:  2010-08       Impact factor: 4.962

2.  The lingering consequences of sepsis: a hidden public health disaster?

Authors:  Derek C Angus
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

3.  Long-term cognitive impairment and functional disability among survivors of severe sepsis.

Authors:  Theodore J Iwashyna; E Wesley Ely; Dylan M Smith; Kenneth M Langa
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

4.  Selective improvement of tumor necrosis factor capture in a cytokine hemoadsorption device using immobilized anti-tumor necrosis factor.

Authors:  Morgan V DiLeo; James D Fisher; Brianne M Burton; William J Federspiel
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2011-01       Impact factor: 3.368

5.  Sepsis induces early alterations in innate immunity that impact mortality to secondary infection.

Authors:  Matthew J Delano; Terri Thayer; Sonia Gabrilovich; Kindra M Kelly-Scumpia; Robert D Winfield; Philip O Scumpia; Alex G Cuenca; Elizabeth Warner; Shannon M Wallet; Mark A Wallet; Kerri A O'Malley; Reuben Ramphal; Michael Clare-Salzer; Philip A Efron; Clayton E Mathews; Lyle L Moldawer
Journal:  J Immunol       Date:  2010-11-24       Impact factor: 5.422

6.  Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis.

Authors:  Kevin R Kasten; Priya S Prakash; Jacqueline Unsinger; Holly S Goetzman; Lisa G England; Cindy M Cave; Aaron P Seitz; Cristina N Mazuski; Tony T Zhou; Michel Morre; Richard S Hotchkiss; David A Hildeman; Charles C Caldwell
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

7.  Toll-like receptors 2 and 4 contribute to sepsis-induced depletion of spleen dendritic cells.

Authors:  Frédéric Pène; Emilie Courtine; Fatah Ouaaz; Benjamin Zuber; Bertrand Sauneuf; Gonzalo Sirgo; Christophe Rousseau; Julie Toubiana; Viviane Balloy; Michel Chignard; Jean-Paul Mira; Jean-Daniel Chiche
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

8.  Peroxisome proliferator-activated receptor {delta} regulates inflammation via NF-{kappa}B signaling in polymicrobial sepsis.

Authors:  Basilia Zingarelli; Giovanna Piraino; Paul W Hake; Michael O'Connor; Alvin Denenberg; Hongkuan Fan; James A Cook
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 5.770

Review 9.  The role of natural killer cells in sepsis.

Authors:  Laurent Chiche; Jean-Marie Forel; Guillemette Thomas; Catherine Farnarier; Fréderic Vely; Mathieu Bléry; Laurent Papazian; Eric Vivier
Journal:  J Biomed Biotechnol       Date:  2011-05-14

10.  B cells enhance early innate immune responses during bacterial sepsis.

Authors:  Kindra M Kelly-Scumpia; Philip O Scumpia; Jason S Weinstein; Matthew J Delano; Alex G Cuenca; Dina C Nacionales; James L Wynn; Pui Y Lee; Yutaro Kumagai; Philip A Efron; Shizuo Akira; Clive Wasserfall; Mark A Atkinson; Lyle L Moldawer
Journal:  J Exp Med       Date:  2011-07-11       Impact factor: 14.307

View more
  15 in total

Review 1.  Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease.

Authors:  Javier Cabrera-Perez; Vladimir P Badovinac; Thomas S Griffith
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

Review 2.  New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.

Authors:  Charles N Serhan; Nan Chiang; Jesmond Dalli
Journal:  Mol Aspects Med       Date:  2017-09-01

Review 3.  Sepsis-induced immune dysfunction: can immune therapies reduce mortality?

Authors:  Matthew J Delano; Peter A Ward
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

4.  PPAR-γ/IL-10 axis inhibits MyD88 expression and ameliorates murine polymicrobial sepsis.

Authors:  Ana Elisa Ferreira; Flavia Sisti; Fabiane Sônego; Suojuan Wang; Luciano Ribeiro Filgueiras; Stephanie Brandt; Ana Paula Moreira Serezani; Hong Du; Fernando Q Cunha; Jose Carlos Alves-Filho; Carlos Henrique Serezani
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

Review 5.  The immune system's role in sepsis progression, resolution, and long-term outcome.

Authors:  Matthew J Delano; Peter A Ward
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

6.  Relationship of serum mannose-binding lectin levels with the development of sepsis: a meta-analysis.

Authors:  Dong-Na Gao; Yu Zhang; Yan-Bo Ren; Jian Kang; Li Jiang; Zhuo Feng; Ya-Nan Qu; Qing-Hui Qi; Xuan Meng
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

7.  BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.

Authors:  Anna C Belkina; Barbara S Nikolajczyk; Gerald V Denis
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

8.  Deletion of the gene encoding calcitonin and calcitonin gene-related peptide α does not affect the outcome of severe infection in mice.

Authors:  Michael J Tuvim; Cecilia G Clement; Eileen Su-Chen Huang; Gilbert J Cote; Scott E Evans; Xiudong Lei; Leonard J Deftos; Robert F Gagel; Burton F Dickey
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

9.  Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis.

Authors:  Amie J Eisfeld; Peter J Halfmann; Jason P Wendler; Jennifer E Kyle; Kristin E Burnum-Johnson; Zuleyma Peralta; Tadashi Maemura; Kevin B Walters; Tokiko Watanabe; Satoshi Fukuyama; Makoto Yamashita; Jon M Jacobs; Young-Mo Kim; Cameron P Casey; Kelly G Stratton; Bobbie-Jo M Webb-Robertson; Marina A Gritsenko; Matthew E Monroe; Karl K Weitz; Anil K Shukla; Mingyuan Tian; Gabriele Neumann; Jennifer L Reed; Harm van Bakel; Thomas O Metz; Richard D Smith; Katrina M Waters; Alhaji N'jai; Foday Sahr; Yoshihiro Kawaoka
Journal:  Cell Host Microbe       Date:  2017-11-16       Impact factor: 21.023

10.  Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27.

Authors:  Markus Bosmann; Birgit Strobl; Nadia Kichler; Doris Rigler; Jamison J Grailer; Florence Pache; Peter J Murray; Mathias Müller; Peter A Ward
Journal:  J Leukoc Biol       Date:  2014-03-06       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.